Gruppo Lepetit S.p.a.

The Dow Chemical Company

Giorgio Tamoni

Francesco Parenti

Carolina Coronelli

Giancarlo Lancini

Giovanni Cassani

Hermes Pagani

Enrico Selva

Giorgio Pirali

Maria Grandi

Grazia Beretta

Vittorio Arioli

Manuela Paternoster

New antibiotic substances arbitrarily designated M 9026 complex, antibiotic M 9026 factor 1, antibiotic M 9026 factor 2, and antibiotic M 9026 factor 3, produced by fermentation of a strain of the Micromonospora genus. The antibiotics of the invention are antimicrobial and antitumor agents.

Antimicrobial and antitumor antibiotic M 9026 and its pure individual

The present invention concerns a new antibiotic substance arbitrarily designated as antibiotic SB 22484, to a process for its production by culturing Streptomyces sp. NRRL 15496 or a producing variant or mutant thereof, and to the use of the new antibiotic substance in the treatment of infectious diseases involving microorganisms susceptible to this antibiotic substance.

Antibiotic SB 22484

The antibiotic gardimycin and process for producing said antibiotic by fermentation of strains belonging to the genus Actinoplanes.

Antibiotic substances

A new antibiotic prepared from aerobic cultivation of Actinoplanes sarveparensis and a method for producing the same from a culture medium.

Antibiotic substance from Actinoplanes sarveparensis CBS 305.76

Gardimycin and process for producing same

Growing community of inventors

Milan, Italy

Giorgio Tamoni